ENOV (Enovis) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ENOV Enovis Corp ENOV
68 GF Score
Price $26.61
GF Value $46.19
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Enovis Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Enovis  (NYSE:ENOV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Enovis Cyclically Adjusted PB Ratio Related Terms


Enovis Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Enovis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis Cyclically Adjusted PB Ratio Chart

Enovis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.58 0.60 0.48 0.31

Enovis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.34 0.31 0.26 0.24

ENOV vs IART, AHCO, INSP: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Enovis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enovis Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Enovis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enovis's Cyclically Adjusted PB Ratio falls into.


ENOV
68GF Score
Enovis Corp ENOV
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enovis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Enovis's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Enovis's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=25.643/333.9520*333.9520
=25.643

Current CPI (Jun. 2026) = 333.9520.

Enovis Quarterly Data

Book Value per Share CPI Adj_Book
201609 72.711 241.428 100.577
201612 70.781 241.432 97.905
201703 73.429 243.801 100.581
201706 77.127 244.955 105.149
201709 80.402 246.819 108.786
201712 85.206 246.524 115.424
201803 87.576 249.554 117.194
201806 83.656 251.989 110.866
201809 83.496 252.439 110.457
201812 83.643 251.233 111.183
201903 91.295 254.202 119.937
201906 78.905 256.143 102.874
201909 75.971 256.759 98.811
201912 87.450 256.974 113.646
202003 83.443 258.115 107.959
202006 84.938 257.797 110.029
202009 86.422 260.280 110.884
202012 89.708 260.474 115.014
202103 93.953 264.877 118.454
202106 90.793 271.696 111.597
202109 88.897 274.310 108.225
202112 88.654 278.802 106.191
202203 85.137 287.504 98.891
202206 64.484 296.311 72.676
202209 62.914 296.808 70.787
202212 63.584 296.797 71.544
202303 63.189 301.836 69.912
202306 63.238 305.109 69.216
202309 63.037 307.789 68.395
202312 62.611 306.746 68.164
202403 60.328 312.332 64.504
202406 59.899 314.175 63.670
202409 59.614 315.301 63.140
202412 45.855 315.605 48.521
202503 45.830 319.799 47.858
202506 45.106 322.561 46.699
202509 35.333 324.800 36.329
202512 26.045 324.054 26.841
202603 25.662 330.213 25.953
202606 25.643 333.952 25.643

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $26.61 is trading 42.4% below its estimated GF Value™ of $46.19. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $46.19 vs. price of $26.61 (42.4% below fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
68GF Score

Get the complete analysis for ENOV

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.61
Price
$46.19
GF Value